A-366833: a novel nicotinonitrile-substituted 3,6-diazabicyclo[3.2.0]-heptane alpha4beta2 nicotinic acetylcholine receptor selective agonist: Synthesis, analgesic efficacy and tolerability profile in animal models.
about
Nicotinic ACh receptors as therapeutic targets in CNS disordersCrystal structure of 2-(2-bromo-phen-yl)-4-(1H-indol-3-yl)-6-(thio-phen-2-yl)pyridine-3-carbo-nitrile.Neuronal nicotinic receptors as analgesic targets: it's a winding roadalpha7 nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analogues.Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties.Crystal structure of 2-benzyl-amino-4-(4-bromo-phen-yl)-6,7-di-hydro-5H-cyclo-penta-[b]pyridine-3-carbo-nitrile.Effects of nicotinic acetylcholine receptor agonists in assays of acute pain-stimulated and pain-depressed behaviors in rats.6-(4-Amino-phen-yl)-4-(4-eth-oxy-phen-yl)-2-meth-oxy-nicotinonitrile6-Meth-oxy-4-(2,4,5-tri-meth-oxy-phen-yl)-2,2'-bi-pyridine-5-carbo-nitrileOpportunities for the replacement of animals in the study of nausea and vomiting6-(4-Amino-phen-yl)-2-meth-oxy-4-phenyl-nicotino-nitrile.Analgesic and antineuropathic drugs acting through central cholinergic mechanismsThe potential of neuronal nicotinic acetylcholine receptor agonists for treating CNS conditions.Chiral aryloxyalkylamines: Selective 5-HT(1B/1D) activation and analgesic activity.Discriminative-stimulus effects of NS9283, a nicotinic α4β2* positive allosteric modulator, in nicotine-discriminating rats.Antihyperalgesic effects of a novel muscarinic agonist (LASSBio-873) in spinal nerve ligation in rats.Preclinical Characterization of A-582941: A Novel α7 Neuronal Nicotinic Receptor Agonist with Broad Spectrum Cognition-Enhancing Properties
P2860
Q28111941-6B83C07A-2E64-4D4A-BBC1-AD4759C45D15Q34291538-88B86A68-1455-43E2-A976-05240D902BC7Q34364181-82488C12-7206-4846-9391-CB630E29EE80Q34586463-3AFCA1C8-1CB2-4B48-9C8C-A958F1FB4971Q34778803-6EF37704-C05A-4792-971D-407F990C0326Q35150819-9813886F-9546-45BA-B6F0-0FE17EC6B8E1Q36186198-30221537-037B-4D71-A0AC-69550103060DQ36214747-9E0FD6FA-9957-4692-8AEC-34D6AFB00180Q37214855-BEE59521-6BD1-4D01-A004-917F185F2158Q37332618-0A934D77-2D76-4BE7-BDC0-D0D99E890BB8Q37450443-92325B1C-9CFA-40EC-9857-6E480D2369B2Q37876436-426A1378-43B2-431E-B309-780D96089AE9Q38090678-DF41127E-67BD-48BC-9A0A-1DEC23CE6C3BQ43126712-4D5E5F9F-B852-47D9-B3F4-C07C122B34F6Q46934653-6D17A8D6-BDE7-4AB8-9EFA-783A94C73CDFQ51076494-72DBA4F0-453A-4309-9AC9-B8D07EE05AB7Q56853416-003CE1F8-AFD1-4828-A430-2CD80D20F876
P2860
A-366833: a novel nicotinonitrile-substituted 3,6-diazabicyclo[3.2.0]-heptane alpha4beta2 nicotinic acetylcholine receptor selective agonist: Synthesis, analgesic efficacy and tolerability profile in animal models.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A-366833: a novel nicotinonitr ...... lity profile in animal models.
@ast
A-366833: a novel nicotinonitr ...... lity profile in animal models.
@en
A-366833: a novel nicotinonitr ...... lity profile in animal models.
@nl
type
label
A-366833: a novel nicotinonitr ...... lity profile in animal models.
@ast
A-366833: a novel nicotinonitr ...... lity profile in animal models.
@en
A-366833: a novel nicotinonitr ...... lity profile in animal models.
@nl
prefLabel
A-366833: a novel nicotinonitr ...... lity profile in animal models.
@ast
A-366833: a novel nicotinonitr ...... lity profile in animal models.
@en
A-366833: a novel nicotinonitr ...... lity profile in animal models.
@nl
P2093
P1476
A-366833: a novel nicotinonitr ...... ility profile in animal models
@en
P2093
Anita Kempf-Grote
Connie Faltynek
David J Anderson
Jianguo Ji
Kennan C Marsh
Lynne E Rueter
Michael D Meyer
Michael J Buckley
Peter Curzon
Tino Dyhring
P304
P356
10.1016/J.BCP.2007.08.010
P407
P577
2007-08-12T00:00:00Z